FN2 Earnings Intelligence
DexCom, Inc. ratios (quarterly)
DexCom, Inc. (DXCM) Ratios (quarterly) derived from persisted SEC financial facts.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 est. | 9/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $621.2 | $904.9 | $1,159 | $1,835.7 | $1,118.2 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $994.2 | $1,036 | $1,157.1 | $1,209.3 | $1,191.9 | $1,290.3 | $1,334.8 |
| % Growth | - | - | - | - | - | 11.5% | 10.4% |
| Gross Profit | $593.8 | $589 | $688.8 | $731.4 | $750.3 | - | - |
| % Margin | 59.7% | 56.9% | 59.5% | 60.5% | 62.9% | - | - |
| EBITDA | - | $193.7 | $275.6 | $306.1 | $322.4 | - | - |
| % Margin | - | 18.7% | 23.8% | 25.3% | 27.0% | - | - |
| Net Income | $134.6 | $105.4 | $179.8 | $283.8 | $199.5 | - | - |
| % Margin | 13.5% | 10.2% | 15.5% | 23.5% | 16.7% | - | - |
| Diluted EPS | $0.34 | $0.27 | $0.45 | $0.70 | $0.51 | $0.61 | $0.67 |
| % Growth | - | - | - | - | - | 35.6% | -3.8% |
| Operating Cash Flow | - | $183.8 | - | - | $525.6 | - | - |
| CapEx | - | $87 | - | - | $76.6 | - | - |
| Free Cash Flow | - | $96.8 | - | - | $449 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 | 6/30/2026 est. | 9/30/2026 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $994.2 | $1,036 | $1,157.1 | $1,209.3 | $1,191.9 | $1,290.3 | $1,334.8 |
| Gross Profit | $593.8 | $589 | $688.8 | $731.4 | $750.3 | - | - |
| EBITDA | - | $193.7 | $275.6 | $306.1 | $322.4 | - | - |
| Net Income | $134.6 | $105.4 | $179.8 | $283.8 | $199.5 | - | - |
| Diluted EPS | $0.34 | $0.27 | $0.45 | $0.70 | $0.51 | $0.61 | $0.67 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Cash & Equivalents | $621.2 | $904.9 | $1,159 | $1,835.7 | $1,118.2 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | - | - | - | - | - |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Operating Cash Flow | - | $183.8 | - | - | $525.6 |
| Capital Expenditure | - | $87 | - | - | $76.6 |
| Free Cash Flow | - | $96.8 | - | - | $449 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 9/30/2024 | 3/31/2025 | 6/30/2025 | 9/30/2025 | 3/31/2026 |
|---|---|---|---|---|---|
| Revenue Growth | - | - | - | - | - |
| Gross Margin | 59.7% | 56.9% | 59.5% | 60.5% | 62.9% |
| EBITDA Margin | - | 18.7% | 23.8% | 25.3% | 27.0% |
| Net Margin | 13.5% | 10.2% | 15.5% | 23.5% | 16.7% |
| FCF Margin | - | 9.3% | - | - | 37.7% |
| Diluted EPS Growth | - | - | - | - | - |